A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

2006 ◽  
Vol 59 (1) ◽  
pp. 79-87 ◽  
Author(s):  
R. O’Connor ◽  
M. O’Leary ◽  
J. Ballot ◽  
C. D. Collins ◽  
P. Kinsella ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Phase I ◽  
Advanced Cancer ◽  
Pharmacokinetic Study ◽  
Multi Drug Resistance ◽  
Resistance Protein

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2129-2129 ◽  
Author(s):  
M. O' Leary ◽  
R. O' Connor ◽  
S. Roy ◽  
J. Ballot ◽  
W. Ooi ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial ◽  
Multi Drug Resistance

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2129-2129
Author(s):  
M. O' Leary ◽  
R. O' Connor ◽  
S. Roy ◽  
J. Ballot ◽  
W. Ooi ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Phase I ◽  
Advanced Cancer ◽  
Phase I Trial ◽  
Multi Drug Resistance

Phase I and Pharmacokinetic Study of Lapatinib and Docetaxel in Patients With Advanced Cancer

2008 ◽  
Vol 26 (18) ◽  
pp. 3051-3056 ◽  
Author(s):  
Patricia M. LoRusso ◽  
Suzanne F. Jones ◽  
Kevin M. Koch ◽  
Nikita Arya ◽  
Ronald A. Fleming ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Pharmacokinetic Study

scholarly journals Uric acid (UA) secretion by avian renal proximal tubule is inhibited by knocking down multi‐drug resistance protein 4 (MRP4)

2007 ◽  
Vol 21 (5) ◽  
Author(s):  
Amy M. Coleman ◽  
James Goldmeyer ◽  
J. Larry Renfro
Keyword(s):  
Drug Resistance ◽  
Uric Acid ◽  
Proximal Tubule ◽  
Renal Proximal Tubule ◽  
Multi Drug Resistance ◽  
Resistance Protein

A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer

2005 ◽  
Vol 23 (4) ◽  
pp. 311-315 ◽  
Author(s):  
Kim N. Chi ◽  
Stephen K. Chia ◽  
Ross Dixon ◽  
Michael J. Newman ◽  
Vince J. Wacher ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Pharmacokinetic Study ◽  
P Glycoprotein

A phase I and pharmacokinetic study of rubitecan, an orally administered topoisomerase I (topo-I) inhibitor, combined with gemcitabine in patients with advanced cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2099-2099 ◽  
Author(s):  
E. Calvo ◽  
E. K. Rowinsky ◽  
A. W. Tolcher ◽  
Q. S. Chu ◽  
M. Beeram ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Pharmacokinetic Study ◽  
Topoisomerase I

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer

2001 ◽  
Vol 48 (2) ◽  
pp. 95-103 ◽  
Author(s):  
Pankaj Bhargava ◽  
John Marshall ◽  
Karen Fried ◽  
Marion Williams ◽  
Patricia Lefebvre ◽  
...  
Keyword(s):  
Phase I ◽  
Advanced Cancer ◽  
Pharmacokinetic Study
Sign in / Sign up

Export Citation Format

Share Document